News Conference News TCT 2014 OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation September 15, 2014
News Industry News New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients September 15, 2014
News Conference News TCT 2014 Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis September 15, 2014
News Conference News TCT 2014 Keynote Address Focuses on Newer DES, Problematic Subgroups September 15, 2014
News Conference News TCT 2014 Expert Discusses Potential Role for Platelet Function, Genetic Testing September 15, 2014
News Conference News TCT 2014 COMBO Stent Achieves Neointimal Regression at 24 Months September 15, 2014
News Industry News Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device September 15, 2014
News Conference News TCT 2014 SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD September 14, 2014
News Conference News TCT 2014 Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent September 14, 2014
News Conference News TCT 2014 NAC, Sodium Bicarbonate Combo Fails to Improve Renal Protection in High-Risk Patients September 14, 2014
News Industry News ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent September 14, 2014
News Conference News TCT 2014 TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape September 14, 2014
News Conference News TCT 2014 Experts Look to Big Data to Identify New Therapeutic Targets for CVD September 14, 2014
News Conference News TCT 2014 PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis September 13, 2014
News Conference News TCT 2014 Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI September 13, 2014
News Daily News Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia September 08, 2014